The label carries a warning about the potential for hypersensitivity reactions to edaravone.<ref name=USlabel2017/>

 


 
The following adverse effects in at least 2% more people given the drug than were given placebo: bruising, gait disturbances, headache, skin inflammation, eczema, problems breathing, excess sugar in urine, and fungal skin infections.<ref name=USlabel2017/>

 

